Loading
Latest filing published 13 Dec 2024 for Lumos Pharma, INC..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Bradley J. Powers is a declared insider of Lumos Pharma, Inc. (board member), with filings sourced from SEC (Form 4). Between 24 August 2019 and 12 December 2024, the trades on record add up to 15 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 13 December 2024, the filings show a transaction in Lumos Pharma, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations